Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine. 2001

P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
Triangle Pharmaceuticals, Durham, North Carolina 27707, USA. furmanpa@tripharm.com

(-)-beta-D-2,6-Diaminopurine dioxolane (DAPD), is a nucleoside reverse transcriptase (RT) inhibitor with activity against human immunodeficiency virus type 1 (HIV-1). DAPD, which was designed as a water-soluble prodrug, is deaminated by adenosine deaminase to give (-)-beta-D-dioxolane guanine (DXG). By using calf adenosine deaminase a K(m) value of 15 +/- 0.7 microM was determined for DAPD, which was similar to the K(m) value for adenosine. However, the k(cat) for DAPD was 540-fold slower than the k(cat) for adenosine. In CEM cells and peripheral blood mononuclear cells exposed to DAPD or DXG, only the 5'-triphosphate of DXG (DXG-TP) was detected. DXG-TP is a potent alternative substrate inhibitor of HIV-1 RT. Rapid transient kinetic studies show the efficiency of incorporation for DXG-TP to be lower than that measured for the natural substrate, 2'-deoxyguanosine 5'-triphosphate. DXG-TP is a weak inhibitor of human DNA polymerases alpha and beta. Against the large subunit of human DNA polymerase gamma a K(i) value of 4.3 +/- 0.4 microM was determined for DXG-TP. DXG showed little or no cytotoxicity and no mitochondrial toxicity at the concentrations tested.

UI MeSH Term Description Entries
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004148 Dioxolanes
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
December 1999, AIDS research and human retroviruses,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
November 2003, Antimicrobial agents and chemotherapy,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
October 1995, Journal of chromatography. B, Biomedical applications,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
June 2007, Antimicrobial agents and chemotherapy,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
January 1999, Nucleosides & nucleotides,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
January 2002, Journal of acquired immune deficiency syndromes (1999),
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
September 2001, Antimicrobial agents and chemotherapy,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
July 2012, Tetrahedron,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
July 2007, Antimicrobial agents and chemotherapy,
P A Furman, and J Jeffrey, and L L Kiefer, and J Y Feng, and K S Anderson, and K Borroto-Esoda, and E Hill, and W C Copeland, and C K Chu, and J P Sommadossi, and I Liberman, and R F Schinazi, and G R Painter
October 2007, AIDS (London, England),
Copied contents to your clipboard!